Therefore, we innovatively put forward hypotheses that gliomas are rich in PYGL-mediated G6P which may participate in tumor growth, and glycogen metabolism is an important event in the tumor immune escape process (40). This evidence concerns the gene PYGL and central nervous system cancer.